Ledger.Open graph →
SEC Form D · filed September 3, 2025

CHARM Therapeutics Inc

Offering
$80.1M
Sold
$17.3M
Exemption
Rule 506(b)
Industry
Other
Location
LONDON, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Gary Glick · Cambridge, MAExec · Director · PromoterMahesh Kudari · LONDON, United KingdomDirectorBriggs Morrison · Cambridge, MADirectorNihal Sinha · Boston, MADirectorKim Blackwell · LONDON, United KingdomDirectorMatthew Mcaviney · LONDON, United KingdomDirectorRishi Gupta · New York, NYDirectorGary Glick · Cambridge, MAExec · Director · PromoterMahesh Kudari · LONDON, United KingdomDirectorBriggs Morrison · Cambridge, MADirectorNihal Sinha · Boston, MADirectorKim Blackwell · LONDON, United KingdomDirectorMatthew Mcaviney · LONDON, United KingdomDirectorRishi Gupta · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗